A detailed history of Polar Asset Management Partners Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 22,700 shares of NTLA stock, worth $273,535. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,700
Previous 45,200 49.78%
Holding current value
$273,535
Previous $1.01 Million 53.91%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.72 - $27.36 $443,700 - $615,600
-22,500 Reduced 49.78%
22,700 $466,000
Q2 2024

Aug 14, 2024

BUY
$20.02 - $27.22 $904,904 - $1.23 Million
45,200 New
45,200 $1.01 Million
Q2 2022

Aug 15, 2022

BUY
$38.49 - $76.21 $1.49 Million - $2.94 Million
38,600 New
38,600 $2 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $916M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.